Dopamine receptor signaling regulates human osteoclastogenesis

Japanese Journal of Clinical Immunology

Volumn 36, Issue 1, 2013, Pages 35-39

  Hanami, Kentaro ^a   Nakano, Kazuhisa ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bone resorption; Dopamine receptor; Osteoclast

Indexed keywords

EID: 84922686587     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.36.35     Document Type: Article

References (12)

1. Meredith EJ, Chamba A, Holder MJ, Barnes NM, Gordon J: Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115(3): 289-295, 2005
2. Basu S, Dasgupta PS: Dopamine, a neurotransmitter, in‰uences the immune system. J Neuroimmunol 102(2): 113-124, 2000
3. Franco R, Pacheco R, Lluis C, Ahern GP, O'Connell PJ: The emergence of neurotransmitters as immune modulators. Trends Immunol 28(9): 400-407, 2007
4. Elefteriou F, Ahn JD, Takeda S, et al.: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434(7032): 514-520, 2005
5. Takeda S, Elefteriou F, Levasseur R, et al.: Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3): 305-317, 2002
6. Sseur R, Sabatier JP, Potrel-Burgot C, Lecoq B, Creveuil C, Marcelli C: Sympathetic nervous system as transmitter of mechanical loading in bone. Joint Bone Spine 70(6): 515-519, 2003
7. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR: Use of beta-blockers and risk of fractures. JAMA 292(11): 1326-1332, 2004
8. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC: Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19(1): 19- 24
9. Xing L, Schwarz EM, Boyce BF: Osteoclast precursors, RANKL/RANK, and immunology.
10. Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7(4): 292-304, 2007
11. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Antagonizing dopamine D1-like receptor inhibits Th17 cell diŠerentiation: preventive and therapeutic eŠects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 373(2): 286-291, 2008
12. Nakashioya H, Nakano K, Watanabe N, Miyasaka N, Matsushita S, Kohsaka H: Therapeutic eŠect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice. Mod Rheumatol; 21(3): 260-266, 2011.